Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/02/2007 | CN1954808A High dose Ambroxol hydrochloride freeze-dried preparation and preparation method |
05/02/2007 | CN1954806A Teprenone orally disintegrating tablet prescription and its preparation method |
05/02/2007 | CN1954804A Therapeutic uses and delivery systems of dehydroepiandrosterone |
05/02/2007 | CN1954803A Spray-dried granules containing pranlukast and processes for the preparation thereof |
05/02/2007 | CN1313476C Injection preparation of arjimycin water soluble phosphate and its preparation method |
05/02/2007 | CN1313459C Total flavone glycoside extract of Radix scutellariae, Rodix scutellariae monomer flavone glycoside, its preparation and use |
05/02/2007 | CN1313439C Compounds and compositions for delivering active agents |
05/02/2007 | CN1313157C Chitose composition for promoting medicine transfer through skin penetration and its use method |
05/02/2007 | CN1313155C Topical composition comprising a cyclofructan, a carrier and a drug |
05/02/2007 | CN1313154C Medicine composition of adding active component which undissolved in water in carrier composition and its preparing method |
05/02/2007 | CN1313148C HSA-free formulations of interferon-Beta |
05/02/2007 | CN1313145C Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
05/02/2007 | CN1313141C Chinese traditional medicine composition for treating hysteromyoma and preparation and quality controlling method thereof |
05/02/2007 | CN1313139C Method for preparing medicine for treating angioneurotic headache |
05/02/2007 | CN1313136C Hemorrhoid-eliminating suppository and process for preparing the same |
05/02/2007 | CN1313133C Medicine composition for treating coronary heart disease and its prepn process |
05/02/2007 | CN1313132C Medicine composition for treating coronary heart disease and its prepn process |
05/02/2007 | CN1313128C Membrane separation process of preparing aloe powder, aloe tincture and aloe water |
05/02/2007 | CN1313123C External used Chinese medicinal preparation for bone fracture and its preparing method |
05/02/2007 | CN1313118C Method for preparing Chinese medicine rapid-release concentrated pill for treating mammary gland poliferation |
05/02/2007 | CN1313117C Chinese medicine external applied powder for bone damage |
05/02/2007 | CN1313115C Zoster treating ointment and its prepn |
05/02/2007 | CN1313114C Chinese traditional medicine decoction for treating heart disease |
05/02/2007 | CN1313113C 'Wudan Xinggan' granular for treating fatty liver, and its prepn. method |
05/02/2007 | CN1313110C Oteoproliferation treating plaster |
05/02/2007 | CN1313105C Pharmaceutical composition for treating angioneurotic migraine |
05/02/2007 | CN1313103C Orally disintegrating tablet of bupleurum root and its preparation |
05/02/2007 | CN1313102C Health caring capsule of soft-shelled turtle and its preparation method |
05/02/2007 | CN1313100C Antitumour Chinese medicine preparation |
05/02/2007 | CN1313099C Carbon gas gel transfusion agent, its preparing method and its use |
05/02/2007 | CN1313092C Sustained-release tablet composition of pramipexole |
05/02/2007 | CN1313087C Preparation method for increasing dissolution of sofalcone |
05/02/2007 | CN1313086C Aarin preparation for injection and preparing process thereof |
05/02/2007 | CN1313085C Application of total hypone of radix cynanchi bungei and hypnone for preparing medicine for treating gastrointestinal tract diseases |
05/02/2007 | CN1313084C Percutaneous contraceptive drugs delivery system and preparing method |
05/02/2007 | CN1313083C Baofukang vagina film agent and its making method |
05/02/2007 | CN1313082C Slow releasing composition and its preparing method |
05/02/2007 | CN1313081C Valacycloguanosine tablet containing colloid silica |
05/02/2007 | CN1313080C Improved water-insoluble drug particle preparing process |
05/02/2007 | CN1313079C Traditional Chinese medicine preparation for treating prostatitis and preparation method thereof |
05/02/2007 | CN1313075C Composition containing semicrystalized polymer gelled liquid fatty phase |
05/02/2007 | CN1313012C Catechin effervescence tablet |
05/01/2007 | US7211662 Soluble highly branched glucose polymers and their method of production |
05/01/2007 | US7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
05/01/2007 | US7211565 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders |
05/01/2007 | US7211283 Casing of a gelatin-free, water- based, set hydrocolloid gel that forms an enclosure, and at least one solid, liquid, soft or particulate center enclosed by the casing |
05/01/2007 | US7211276 Method for preventing ulceration or irritation of mucosa |
05/01/2007 | US7211275 For drug, protein and gene delivery |
05/01/2007 | US7211274 Hair growth formulation |
05/01/2007 | US7211273 Capsules contain a hydrophobic continuous phase comprising an isotropic mixture of a thermoplastic-type block copolymer and hydrocarbon oil, and a surfactant; preferably contains an oil-soluble benefit agent |
05/01/2007 | US7211272 Drug delivery device |
05/01/2007 | US7211267 Methods of treating acne |
05/01/2007 | US7211266 Calcium sulfate hemihydrate, calcium sulfate dihydrate, and a binder; and an aqueous mixing solution; optionally stearic acid |
05/01/2007 | US7211261 Stable liquid formulations of botulinum toxin |
05/01/2007 | US7211249 Heat-generating composition for topical application to skin |
05/01/2007 | US7211248 Controlling lipid metabolism; injecting a solution of Dna, Rna gene using gas microbubbles using ultrasonic frequency; gene expression |
05/01/2007 | US7211115 Prosthetic foot with tunable performance |
05/01/2007 | US7211076 Medical device for fluid delivery having low fluid flow rate |
05/01/2007 | US7211070 Device and method for exothermic treatment of eyelid diseases |
05/01/2007 | CA2431397C Self emulsifying lipid matrix (selm) |
05/01/2007 | CA2366679C Stabilized oral pharmaceutical composition containing iodide and iodate and method |
05/01/2007 | CA2326756C Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients |
05/01/2007 | CA2290893C Magnesium omeprazole |
05/01/2007 | CA2278814C Electro-release systems, modified electrodes and their use |
05/01/2007 | CA2271004C Process for the preparation of optically pure isomers of formoterol |
05/01/2007 | CA2254060C Effervescent bisphosphonate formulation |
05/01/2007 | CA2249637C Uniform drug delivery therapy |
05/01/2007 | CA2244997C Sustained delivery of an active agent using an implantable system |
05/01/2007 | CA2244357C A novel pharmaceutical composition for inhalation containing cr 2039 (andolast) |
05/01/2007 | CA2234585C Prolonged release of gm-csf |
05/01/2007 | CA2214343C Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |
05/01/2007 | CA2148632C Topical medicament having cicatrizing activity |
05/01/2007 | CA2143636C Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
05/01/2007 | CA2129773C Aromatic carboxylic acid derivatives |
04/30/2007 | CA2554874A1 Methods of reducing alcohol-induced dose dumping for hydromorphone sustained release oral dosage forms |
04/30/2007 | CA2554701A1 Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms |
04/30/2007 | CA2554698A1 Methods of reducing alcohol-induced dose dumping for hydrocodone sustained release oral dosage forms |
04/30/2007 | CA2554697A1 Methods of reducing alcohol-induced dose dumping for morphine sustained release oral dosage forms |
04/30/2007 | CA2554693A1 Methods of reducing alcohol-induced dose dumping for oxymorphone sustained release oral dosage forms |
04/30/2007 | CA2554684A1 Methods of reducing alcohol-induced dose dumping for oxycodone sustained release oral dosage forms |
04/27/2007 | CA2564456A1 Methods and compositions for epilation |
04/26/2007 | WO2007048121A2 Methods of preparing targeted immunoliposomes |
04/26/2007 | WO2007048046A2 Sirna silencing of filovirus gene expression |
04/26/2007 | WO2007048000A2 Neural stimulation system and optical monitoring systems and methods |
04/26/2007 | WO2007047607A2 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
04/26/2007 | WO2007047539A2 Localized delivery to the lymphatic system |
04/26/2007 | WO2007047497A1 Therapy patch |
04/26/2007 | WO2007047482A2 Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics |
04/26/2007 | WO2007047371A2 Pharmaceutical packaging of an oral dosage combination |
04/26/2007 | WO2007047047A2 Polymorph transformation of zolpidem in tablet matrix |
04/26/2007 | WO2007047040A2 Directly compressible extended release alprazolam formulation |
04/26/2007 | WO2007046890A1 Lozenge for treatment of dry mouth and related conditions |
04/26/2007 | WO2007046775A1 Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom |
04/26/2007 | WO2007046590A1 New sustained-release multiple unit dosage form |
04/26/2007 | WO2007046411A1 Method for stabilization of isoxazole compound |
04/26/2007 | WO2007046315A1 External preparation for skin |
04/26/2007 | WO2007046291A1 Dry coating using biaxial kneader |
04/26/2007 | WO2007045897A1 Aerosol valve |
04/26/2007 | WO2007045689A2 Inhalatory pharmaceutical compositions in form of dry powders, solutions or suspensions |
04/26/2007 | WO2007045616A1 Thermoset particles and methods for production thereof |